Cerapedics, Inc.

Welcome to Cerapedics! Learn more about i-FACTOR

Cerapedics is a global, commercial-stage orthopedics company that is dedicated to redefining the path to bone repair by healing bones faster and at higher rates, so all patients can get back to living their fullest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma, and interventional procedures worldwide. Cerapedics has two products approved by the FDA: PearlMatrix™ and i-FACTOR P-15 Peptide Enhanced Bone Grafts.

Brands: i-FACTOR® Putty is available in the USA and many countries around the world.

 Press Releases

• Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced B (Aug 19, 2025)
  WESTMINSTER, Colo., June 23, 2025 – Cerapedics Inc. a global, commercial-stage orthopedics company today announced the U.S. FDA premarket approval of PearlMatrix™. 

• Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Pe (Aug 19, 2025)
  WESTMINSTER, Colo., July 8, 2025 – Cerapedics Inc. today announced the successful completion of the first patient treated with PearlMatrix™.

• Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced B (Oct 27, 2025)
  PearlMatrix^TM P-15 Peptide Enhanced Bone Graft is the first and only bone growth accelerator shown to accelerate lumbar fusion in overall patient populations.

 Featured Products